For more information, please refer to the section below
For reproducible, lab-grade results, documentation is everything
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
The two medications that will be the focus of this article are dulaglutide and semaglutide
These agents, which have shown efficacy in non-transplant populations, present new opportunities for improving the management of diabetes mellitus in liver transplant recipients, potentially mitigating the adverse effects of PTDM and enhancing long-term outcomes
Pharmacological management of obesity: an endocrine Society clinical practice guideline